Inviting applications for Group Leader positions at DANDRITE, MIMS and FIMM

Join our partnership between four Nordic research nodes and EMBL, to stand together at the forefront of molecular medicine research. Apply before 31 July, or 6 September 2023. Read more.

DANDRITE

The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

FIMM

The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

MIMS

The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

NCMM

Centre for Molecular Medicine Norway (NCMM) is the Norwegian node of the Nordic EMBL Partnership. NCMM conducts molecular medicine & biotech research and works translate these findings into clinical practice. 

 

About 

News 

Collaborations

Research

Technologies

Training

Careers

 

 

 

Follow us

Twitter: @NordicEMBL

Facebook.com/NordicEMBL

linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

 

The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

 

Revised 29.06.2023